Illumina, Inc Sole Source, Commodities, repair, and maintenance FY25 thru FY26

The Illinois Department of Public Health (IDPH), specifically the Office of Disease Control, has awarded a sole source contract to Illumina, Inc. for advanced genomic sequencing equipment, services, and software. The contract, valued at $826,536.50, covers a one-year performance period from August 1, 2025, to July 31, 2026. The procurement encompasses multiple high-precision scientific instruments, including one iSeq 100 system with advance exchange, four MiSeq Dx instruments, and four NextSeq 2000 systems, each with a Silver Support Plan for maintenance and repair.

In addition to the hardware support, the contract includes complementary software and analytical tools critical for public health research and epidemiological investigations. These include a BaseSpace Sequence Hub Enterprise Annual Subscription, Illumina Analytics with 5,000 iCredits, and reagent packages designed for whole genome sequencing. The sole source justification highlights Illumina's unique position as the exclusive manufacturer of these proprietary technologies, which are essential for supporting advanced diagnostic capabilities in newborn screening, pathogen typing, and complex disease investigations across Illinois's public health infrastructure.